The US Ambassador to Bangladesh, Dan W. Mozena, visited the state-of-the-art manufacturing facilities of Beximco Pharmaceuticals Ltd. (BPL) at Tongi yesterday (November 4, 2014, Tuesday). He was accompanied by Daniel Keen, Economic Commercial Officer and other officials of the Embassy.
US ambassador was welcomed at the plant premises by Nazmul Hassan, MP, Managing Director of BPL. Chief Operating Officer Rabbur Reza and other senior officials from the company were present on this occasion.
Visiting the state art facility Mozena said “Bangladesh is the next economic tiger in the region and pharma industry will play a vital role for this.”
“He will attract the US businessmen to import drug from Bangladesh” He added.
Nazmul Hassan MP briefed him about the company activities as well as current status and future prospects of Bangladesh Pharma industry. The ambassador was told that the company currently has the highest number of global accreditations in the sector and the country is emerging as a global generic drug hub in the region with increasing focus on regulated markets. After visiting the facilities, Dan Mozena and the delegates expressed high satisfaction over the world class operation and quality control practices of Beximco Pharma.
It is worth mentioning here that Beximco Pharmaceuticals Ltd. is a leading manufacturer and exporter of pharmaceuticals in the country and its state-of-the-art manufacturing facilities are certified by global regulatory bodies such as TGA (Australia), AGES (EU), ANVISA (Brazil), GCC (Gulf Member Countries), INVIMA (Colombia), TFDA (Taiwan) among others.
About Beximco Pharmaceuticals Limited
Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients. The Company produces branded generics for almost all diseases. BPL also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2,400 employees.
The Company’s products are sold to retail outlets, hospitals, clinics in Bangladesh as well as in regional markets such as Srilanka, Myanmar, Nepal, Bhutan, Cambodia, Kenya, and Singapore, among others.